These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 14184800)

  • 1. [EXPERIMENTAL STUDY OF RIFAMYCIN SV. (PRELIMINARY REPORT)].
    HERRERAMALMSTEN L; BORRASCUESTA F; HERRERACARVAJAL C
    Chemotherapia (Basel); 1963; 10():621-35. PubMed ID: 14184800
    [No Abstract]   [Full Text] [Related]  

  • 2. [RESISTANCE OF TUBERCLE BACILLI TO STREPTOMYCIN, ISONICOTINIC ACID HYDRAZIDE AND P-AMINOSALICYLIC ACID IN VITRO AND IN VIVO].
    JASIELSKARUDNICKA M
    Med Dosw; 1963; 25():55-78. PubMed ID: 14108261
    [No Abstract]   [Full Text] [Related]  

  • 3. [FIRST EXPERIENCES IN THE USE OF RIFAMYCIN SV ASSOCIATED WITH PAS USING THE METHOD OF VENOUS PERFUSION. CLINICAL CONTRIBUTION].
    CURCI G; MAURO G
    Minerva Med; 1964 Dec; 55():3964-7. PubMed ID: 14247991
    [No Abstract]   [Full Text] [Related]  

  • 4. [STUDY ON BCG STRAIN VARIANTS RESISTANT TO STREPTOMYCIN, INH AND PAS. II. VACCINANT PROPERTIES IN THE ABSENCE OR PRESENCE OF A TREATMENT WITH THE HOMOLOGOUS TUBERCULOSTATIC].
    BOTEZ V; PARASCHIVESCO M; GHEORGHIU M; ANGELESCO I; BONCIU C; PETROVICI M
    Arch Roum Pathol Exp Microbiol; 1963; 22():951-60. PubMed ID: 14170981
    [No Abstract]   [Full Text] [Related]  

  • 5. ["PERSISTANCE" OF THE "SENSITIVE" KOCH BACILLI. CLINICO-EXPERIMENTAL STUDY].
    LERNER S
    Rev Esp Tuberc; 1963 Oct; 32():497-505. PubMed ID: 14123028
    [No Abstract]   [Full Text] [Related]  

  • 6. [STUDY ON BCG STRAIN VARIANTS RESISTANT TO STREPTOMYCIN, INH AND PAS. I. ANTIGENIC PROPERTIES AND VIRULENCE IN THE ABSENCE OR PRESENCE OF A TREATMENT WITH HOMOLOGOUS TUBERCULOSTATIC].
    BOTEZ V; PARASCHIVESCO M; GHEORGHIU M
    Arch Roum Pathol Exp Microbiol; 1963 Sep; 23():609-16. PubMed ID: 14165837
    [No Abstract]   [Full Text] [Related]  

  • 7. PRIMARY DRUG RESISTANCE AND PULMONARY TUBERCULOSIS. EMERGENCE OF PRIMARY DRUG RESISTANCE.
    RAUNIO O; ELO O
    Ann Med Intern Fenn; 1964; 53():113-22. PubMed ID: 14233850
    [No Abstract]   [Full Text] [Related]  

  • 8. [COMBINATION OF ETHIONAMIDE AND P-AMINOSALICYLIC ACID IN THE TREATMENT OF PULMONARY TUBERCULOSIS WITH GERMS RESISTANT TO ISONIAZID AND STREPTOMYCIN].
    PEREZ JA; FARIAS CE; AMADIO G; CAFURE N
    Prensa Med Argent; 1963 Dec; 50():3280-1. PubMed ID: 14184234
    [No Abstract]   [Full Text] [Related]  

  • 9. AMINO ACIDS ACTIVATION IN TUBERCULOSIS BACILLI OF VARIOUS ANTIBACILLAR DRUGS SENSIVITY.
    HIEROWSKI M; WESTFAL I
    Bull Soc Amis Sci (Med) (Poznan); 1963; 12():17-23. PubMed ID: 14104990
    [No Abstract]   [Full Text] [Related]  

  • 10. The clinical significance of initial resistance to para-aminosalicylic acid in Mycobacteria tuberculosis sensitive to isoniazid and to streptomycin.
    HARLAND RD
    East Afr Med J; 1962 Dec; 39():689-93. PubMed ID: 13960782
    [No Abstract]   [Full Text] [Related]  

  • 11. ALTERNATING REGIMENS OF STREPTOMYCIN-PYAZINAMIDE, ISONIAZID-PARA-AMINOSALICYLIC ACID AT BATTEY STATE HOSPITAL.
    CORPE RF; BLALOCK FA
    Am Rev Respir Dis; 1964 Aug; 90():262-5. PubMed ID: 14198672
    [No Abstract]   [Full Text] [Related]  

  • 12. [DETERMINATION OF THE RESISTANCE OF TUBERCULOSIS BACTERIA IN THE SERIAL DILUTION TEST AND IN THE VERTICAL DIFFUSION TEST].
    KALICH R; GERLOFF W; KREBS A; SCHMIEDEL A
    Beitr Klin Tuberk Spezif Tuberkuloseforsch; 1965 Jan; 129():353-69. PubMed ID: 14273020
    [No Abstract]   [Full Text] [Related]  

  • 13. A STUDY ON PRIMARILY DRUG-RESISTANT STRAINS OF TUBERCLE BACILLI IN SHANGHAI. THE INCIDENCE AND VIRULENCE OF THE RESISTANT BACILLI.
    CHENG TY; TSUI HP; TUNG C; CHEN TM; CHANG KS; LI TS
    Chin Med J; 1964 May; 83():316-8. PubMed ID: 14169964
    [No Abstract]   [Full Text] [Related]  

  • 14. Initial resistance to isoniazid para-aminosal-icylic acid and streptomycin in two areas in Kenya.
    GROUNDS JG
    East Afr Med J; 1962 Dec; 39():682-7. PubMed ID: 13950853
    [No Abstract]   [Full Text] [Related]  

  • 15. [SOURCES OF ERROR IN THE DETERMINATION OF DRUG RESISTANCE OF TUBERCULOSIS BACTERIA].
    FODOR T; TARNOK I; CZANIK P
    Tuberk Tudobetegsegek; 1963 Sep; 16():260-3. PubMed ID: 14091730
    [No Abstract]   [Full Text] [Related]  

  • 16. [The problem of primary drug resistance and tuberculosis].
    IWAZAKI T
    Sogo Rinsho; 1963 Jun; 12():1108-14. PubMed ID: 13957120
    [No Abstract]   [Full Text] [Related]  

  • 17. [THE FREQUENCY OF APPEARANCE AND MICROBIOLOGICAL CLASSIFICATION OF ATYPICAL ACID-FAST BACILLI CULTURED FROM PATIENT MATERIAL].
    ZDUNCZYNK PAWELEK H; BLITEK GOLC D; KOSTRZEWSKA K
    Gruzlica (1926); 1964 Jan; 32():11-22. PubMed ID: 14127495
    [No Abstract]   [Full Text] [Related]  

  • 18. The treatment of patients harbouring tubercle bacilli resistant to isoniazid, streptomycin and PAS.
    JANCIK E
    Rev Czech Med; 1962; 8():200-13. PubMed ID: 13957320
    [No Abstract]   [Full Text] [Related]  

  • 19. [TRIPLE SCHEMA IN THE TREATMENT OF TUBERCULOSIS].
    LAUROC DE
    Rev Paul Med; 1964 Jan; 64():57-62. PubMed ID: 14137921
    [No Abstract]   [Full Text] [Related]  

  • 20. CHEMOTHERAPY FOR PATIENTS WITH CULTURES RESISTANT TO STREPTOMYCIN, ISONIAZID AND PAS.
    JANCIK E; ZELENKA M; TOUSEK J; MAKOVA M
    Tubercle; 1963 Dec; 44():443-5. PubMed ID: 14101324
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.